Pneumoconiosis
Pneumoconiosis is the general term for a class of interstitial lung diseases where inhalation of dust has caused interstitial fibrosis. The three most common types are asbestosis, silicosis, and coal miners lung. Pneumoconiosis often causes restrictive impairment, although diagnosable pneumoconiosis can occur without measurable impairment of lung function. Depending on extent and severity, it may cause death within months or years, or it may never produce symptoms. It is usually an occupational lung disease, typically from years of dust exposure during work in mining; textile milling; shipbuilding, ship repairing, and/or shipbreaking; sandblasting; industrial tasks; rock drilling (subways or building pilings); or agriculture. It is one of the most common occupational diseases in the world.

Types
Depending upon the type of dust, the disease is given different names:

Coalworkers pneumoconiosis (also known as coal miners lung, black lung or anthracosis) – coal, carbon
Aluminosis – Aluminium
Asbestosis – asbestos
Silicosis (also known as "grinders disease" or Potters rot) – crystalline silica dust
Bauxite fibrosis – bauxite
Berylliosis – beryllium
Siderosis – iron
Byssinosis –  Byssinosis is caused by cotton dust inhalation and typically demonstrates a different pattern of lung abnormalities than most other pneumoconiosis.
Chalicosis – fine dust from stonecutting
Silicosiderosis (also sometimes called iron miners lung) – mixed dust containing silica and iron
Labrador lung (found in miners in Labrador, Canada) – mixed dust containing iron, silica and anthophyllite, a type of asbestos
Stannosis – tin oxide
Talcosis – talc
Baritosis - a benign type of pneumoconiosis caused by barium inhalation; it typically causes little  or no overgrowth, hardening, and/or fibrosis.
Mixed-dust pneumoconiosis

Pathogenesis
The reaction of the lung to mineral dusts depends on many variables, including size, shape, solubility, and reactivity of the particles. For example, particles greater than 5 to 10 μm are unlikely to reach distal airways, whereas particles smaller than 0.5 μm move into and out of alveoli, often without substantial deposition and injury. Particles that are 1 to 5 μm in diameter are the most dangerous, because they get lodged at the bifurcation of the distal airways. Coal dust is relatively inert, and large amounts must be deposited in the lungs before lung disease is clinically detectable. Silica, asbestos, and beryllium are more reactive than coal dust, resulting in fibrotic reactions at lower concentrations. Most inhaled dust is entrapped in the mucus blanket and rapidly removed from the lung by ciliary movement. However, some of the particles become impacted at alveolar duct bifurcations, where macrophages accumulate and engulf the trapped particulates. The pulmonary alveolar macrophage is a key cellular element in the initiation and perpetuation of lung injury and fibrosis. Many particles activate the inflammasome and induce IL-1 production. The more reactive particles trigger the macrophages to release a number of products that mediate an inflammatory response and initiate fibroblast proliferation and collagen deposition. Some of the inhaled particles may reach the lymphatics either by direct drainage or within migrating macrophages and thereby initiate an immune response to components of the particulates and/or to self-proteins that are modified by the particles. This then leads to an amplification and extension of the local reaction. Tobacco smoking worsens the effects of all inhaled mineral dusts, more so with asbestos than with any other particle.

Diagnosis
Typical indications on patient assessment include:
Cough
Shortness of breath
Chest tightness
Chest X-ray may show a characteristic patchy, subpleural, bibasilar interstitial infiltrates or small cystic radiolucencies called honeycombing, particularly in advanced disease.Pneumoconiosis in combination with multiple pulmonary rheumatoid nodules in rheumatoid arthritis patients is known as Caplans syndrome.

Epidemiology
The prevalence as of 2021 of pneumoconiosis is around 527,500 cases, with over 60,000 new patients reported globally in 2017. Prevalence has trended somewhat downward since 2015. The mortality of pneumoconiosis patients remained at a high level in recent years, with over 21,000 deaths each year since 2015. It is likely that pneumoconiosis is under-diagnosed and under-reported, especially in countries without highly developed healthcare systems.

Treatment and Prognosis
Lung damage due to pneumoconiosis cannot be reversed. However, some steps can slow down disease progression and relieve symptoms. These include the prescription of medications and breathing treatments to open airways and reduce inflammation. Pulmonary rehabilitation and supplemental oxygen may also be recommended. A lung transplant may be needed in cases of serious diseases. If the patient smokes, smoking cessation is also important. Regular testing, such as X-rays or lung function tests, may be indicated to monitor disease progression.

Prevention
To reduce the likelihood of developing pneumoconiosis, individuals working in affected industries should wear a mask, wash skin that comes in contact with dust, remove dust from clothing and wash the face and hands before eating or drinking. In addition, governments often regulate industry, especially mines, to limit how much dust is in the air. In the United States, coal miners injured by pneumoconiosis and their families may receive monthly payments and medical benefits under the Black Lung Benefits Act.

See also
Aluminosis
Black Lung Benefits Act of 1972
Chalicosis
Philip DArcy Hart
Pneumonoultramicroscopicsilicovolcanoconiosis
Popcorn workers lung disease — diacetyl emissions and airborne dust from butter flavorings used in microwave popcorn production

References
Further reading
Cochrane, A.L.; Blythe, M. (1989). One Mans Medicine, an autobiography of Professor Archie Cochrane. London: BMJ Books. ISBN 0727902776. (Paperback ed. (2009) Cardiff University ISBN 0954088433.

External links

"Pneumoconioses". NIOSH Safety and Health Topic. Center for Disease Control. 30 March 2022.
"Black Lung Benefits Act". U.S. Department of Labor. Archived from the original on 2010-05-27. Retrieved 2007-03-02.
Coal Workers Pneumoconiosis at Merck Manual of Diagnosis and Therapy Professional Edition
Black Lung — United Mine Workers of America
"Black Lung" (PDF). U.S. Department of Labor Mine Safety and Health Administration. Archived from the original (PDF) on 2010-05-30.
A Conversation about Mining and Black Lung Disease
Flavorings-Related Lung Disease
The Institute of Occupational Medicine and its research into pneumocomiosis
Miller, B.G.; Kinnear, A.G. Pneumoconiosis in coalminers and exposure to dust of variable quartz content (PDF) (Technical report). Institute of Occupational Medicine. TM/88/17.